Last reviewed · How we verify

Mix-and-Match PanOptix/Vivity

Berkeley Eye Center · FDA-approved active Small molecule

A mix-and-match intraocular lens combination that pairs PanOptix and Vivity multifocal/extended depth of focus technologies to optimize vision across multiple distances.

A mix-and-match intraocular lens combination that pairs PanOptix and Vivity multifocal/extended depth of focus technologies to optimize vision across multiple distances. Used for Cataract surgery with presbyopia correction in patients desiring multifocal or extended depth of focus vision.

At a glance

Generic nameMix-and-Match PanOptix/Vivity
SponsorBerkeley Eye Center
ModalitySmall molecule
Therapeutic areaOphthalmology
PhaseFDA-approved

Mechanism of action

This approach combines two different presbyopia-correcting lens designs in a single eye or bilaterally to leverage the strengths of each technology. PanOptix uses trifocal diffractive optics for near, intermediate, and distance vision, while Vivity uses extended depth of focus technology. The combination aims to provide superior visual outcomes across the full range of distances while minimizing unwanted optical effects like halos or glare.

Approved indications

Common side effects

Key clinical trials

Primary sources

Every claim on this page is sourced from regulatory or scientific primary sources. See our editorial policy for full methodology.

SourceUsed for
ClinicalTrials.govTrial enrolment, design, endpoints, results

Competitive intelligence

For the full competitive landscape — auto-detected comparators, recent regulatory actions across the set, upcoming PDUFA, patent timeline, sponsor landscape: